InsidersTradesSigma
Follow the 대원제약 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 대원제약 has recorded 1 insider filings. Market capitalisation: €158.4bn. The latest transaction was filed on 13 March 2026 (Purchase). Among the most active insiders: 임한일. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Daewon Pharmaceutical is a South Korean company specializing in the healthcare and pharmaceutical sector. It is listed on the XKRX market.